Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAP2K1 | Q02750 | 13/20 | 0.79 |
| ▸ | MAP2K2 | P36507 | 2/20 | 0.79 |
| ▸ | SMC2 | O95347 | 1/20 | 0.79 |
| ▸ | EGFR | P00533 | 1/20 | 0.79 |
| ▸ | CSNK2A2 | P19784 | 1/20 | 0.79 |
| ▸ | SMC1A | Q14683 | 1/20 | 0.79 |
| ▸ | AAK1 | Q2M2I8 | 1/20 | 0.79 |
| ▸ | Q6ZSR9 | Q6ZSR9 | 1/20 | 0.79 |
| ▸ | BMP2K | Q9NSY1 | 1/20 | 0.79 |
| ▸ | ABCB11 | O95342 | 1/20 | 0.66 |
| ▸ | NQO2 | P16083 | 1/20 | 0.66 |
| ▸ | HDAC3 | O15379 | 8/20 | 0.47 |
| ▸ | HDAC4 | P56524 | 8/20 | 0.47 |
| ▸ | HDAC1 | Q13547 | 8/20 | 0.47 |
| ▸ | HDAC7 | Q8WUI4 | 8/20 | 0.47 |
| ▸ | HDAC2 | Q92769 | 8/20 | 0.47 |
| ▸ | HDAC10 | Q969S8 | 8/20 | 0.47 |
| ▸ | HDAC11 | Q96DB2 | 8/20 | 0.47 |
| ▸ | HDAC8 | Q9BY41 | 8/20 | 0.47 |
| ▸ | HDAC6 | Q9UBN7 | 8/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14067358 | 1.00 | MAP2K1 (0.79) | MAP2K1MAP2K2SMC2EGFRCSNK2A2 | |
| SCHEMBL14067351 | 0.99 | MAP2K1 (0.80) | MAP2K1MAP2K2SMC2EGFRCSNK2A2 | |
| SCHEMBL14067350 | 0.97 | MAP2K1 (0.81) | MAP2K1MAP2K2SMC2EGFRCSNK2A2 | |
| SCHEMBL8064131 | 0.96 | MAP2K1 (0.74) | MAP2K1MAP2K2SMC2EGFRCSNK2A2 | |
| SCHEMBL14067380 | 0.96 | MAP2K1 (0.74) | MAP2K1MAP2K2SMC2EGFRCSNK2A2 | |
| SCHEMBL14067379 | 0.95 | MAP2K1 (0.75) | MAP2K1MAP2K2SMC2EGFRCSNK2A2 | |
| SCHEMBL8070127 | 0.94 | MAP2K1 (0.69) | MAP2K1MAP2K2SMC2EGFRCSNK2A2 | |
| SCHEMBL14067369 | 0.93 | MAP2K1 (0.76) | MAP2K1MAP2K2SMC2EGFRCSNK2A2 | |
| SCHEMBL4536720 | 0.92 | MAP2K1 (0.79) | MAP2K1MAP2K2SMC2EGFRCSNK2A2 | |
| SCHEMBL8064112 | 0.92 | MAP2K1 (0.66) | MAP2K1MAP2K2SMC2EGFRCSNK2A2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2009036020-A1 | MEK INHIBITORS CONTAINING A ZINC BINDING MOIETY | CURIS, INC. (US) | 2009-03-19 | — | — | WO | disclosed |
| US-20080221132-A1 | Multi-Functional Small Molecules as Anti-Proliferative Agents | CURIS, INC. | 2008-09-11 | — | — | US | disclosed |
| US-20080221132-A1 | Multi-Functional Small Molecules as Anti-Proliferative Agents | CURIS, INC. | 2008-09-11 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080221132-A1 | Multi-Functional Small Molecules as Anti-Proliferative Agents | HDAC1, HDAC6, HDAC5 | MAP2K1 42/4885MAP2K2 32/4885SMC2 502/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.